Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon
CoMeC
Retrospective, Uncontrolled Multcentric Cohort Study on the Therapy of Chronic Megalon (CoMeC)
1 other identifier
observational
67
1 country
1
Brief Summary
The aim of this retrospective cohort study is to analyze all available data of patients with chronic megacolon in three clinical centers with respect of conservative and surgical therapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 10, 2020
CompletedStudy Start
First participant enrolled
May 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedApril 27, 2022
April 1, 2022
1.7 years
April 7, 2020
April 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Constipation
Number of constipation crises leading to further hospital admissions: n
One year after inpatient treatment (conservative/surgery)
Secondary Outcomes (2)
Hospital stay
Three months after inpatient treatment (conservative/surgery)
Adverse events
30 days after inpatient treatment (conservative/surgery)
Interventions
There are no guidelines to direct surgical therapy in patients with chronic megacolon. Historically, it is the surgeons individual choice to use one of the above mentioned surgical treatments. Therefore, the aim of this study is to analyze the success and downsides of the different surgical approaches.
There are no guidelines to direct laxative measures in patients with chronic megacolon. Historically, it is the gastroenterologists individual choice to use one of the above mentioned laxative measures. Therefore, the aim of this study is to analyze the success and downsides of the different Laxative measures.
Eligibility Criteria
The databases of three clinical centers were systematically screened for patients with chronic megacolon (exclusion/inclusion criteria) in the time frame from 1.5.2005 to 1.5.2020.
You may qualify if:
- Chronic megacolon (colon diameter \> 90 mm)
You may not qualify if:
- Toxic megacolon
- Ogilvie-syndrome
- Hirschsprung disease
- Mechanical colorectal obstruction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Theresienkrankenhaus und St. Hedwigkliniken GmbH
Mannheim, 68165, Germany
Related Publications (4)
Hanauer SB, Wald A. Acute and chronic megacolon. Curr Treat Options Gastroenterol. 2007 Jun;10(3):237-47. doi: 10.1007/s11938-007-0017-z.
PMID: 17547862BACKGROUNDO'Dwyer RH, Acosta A, Camilleri M, Burton D, Busciglio I, Bharucha AE. Clinical Features and Colonic Motor Disturbances in Chronic Megacolon in Adults. Dig Dis Sci. 2015 Aug;60(8):2398-407. doi: 10.1007/s10620-015-3645-5. Epub 2015 Apr 14.
PMID: 25868630BACKGROUNDWang XJ, Camilleri M. Chronic Megacolon Presenting in Adolescents or Adults: Clinical Manifestations, Diagnosis, and Genetic Associations. Dig Dis Sci. 2019 Oct;64(10):2750-2756. doi: 10.1007/s10620-019-05605-7. Epub 2019 Apr 5.
PMID: 30953226BACKGROUNDSchmitz D, Meier E, Axt S, Arlt G, Kienle P, Johannink J, Konigsrainer A, Mohammad O, Jakobs R, Willis S, Demir IE, Friess H, Hetjens S, Ebert MP, Reissfelder C, Vassilev G. Conservative versus surgical therapy for idiopathic and secondary megacolon or megarectum in adults - a retrospective multicentre controlled study. Z Gastroenterol. 2024 Nov;62(11):1913-1923. doi: 10.1055/a-2360-5008. Epub 2024 Sep 11.
PMID: 39260392DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Schmitz, PhD, MD
Theresienkrankenhaus und St.Hedwigkliniken Mannheim,University of Heidelberg
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2020
First Posted
April 10, 2020
Study Start
May 7, 2020
Primary Completion
December 31, 2021
Study Completion
March 15, 2022
Last Updated
April 27, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share